Clinical trial
A Randomised Phase III Study of Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast
NCT00470236 is registered in ClinicalTrials.gov with Trans Tasman Radiation Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised Phase III Study of Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast
- Lead sponsor
- Trans Tasman Radiation Oncology Group
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 30, 2007
- Completion date
- June 30, 2024
- Enrollment
- 1,608 (actual)
- Sites
- 120
Conditions
As the registry lists them; a condition with its own page is linked.